Skip to content

INfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia

INfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02750072
Acronym
INSURT
Enrollment
248
Registered
2016-04-25
Start date
2016-09-13
Completion date
2023-10-12
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Knee Pain Syndrome, Tibial Fractures

Brief summary

This study will investigate the incidence and severity of anterior knee pain comparing two different approaches to tibial nail fixation; Infrapatellar versus percutaneous semi-extended suprapatellar incisions. Half the patients will be randomized to the gold standard infrapatellar approach with the other half being randomized to treatment with the percutaneous semi-extended suprapatellar approach.

Detailed description

There are a number of ways to approach the tibial canal when using an intramedullary nail for fracture fixation. The gold standard is the infrapatellar approach (below the knee cap). This approach has the patient positioned with the knee flexed at 90 degrees or greater on the operating table. However, there are challenges with this approach, including imaging, placement of supplemental fixation, conversion to open reduction when necessary and malunion with apex anterior angulation for proximal tibial fractures. The positioning of the patient causes tension on the structures and soft tissues around the knee which can hinder the placement of the nail and can cause damage to the soft tissues that can result in significant long-term anterior knee pain for many patients. The semi-extended suprapatellar approach has the patient positioned in approximately 15-20 degrees of flexion, putting less tension on the structures and soft tissues about the knee and enables the surgeon to insert the nail in an optimal position with relative ease.

Interventions

Infrapatellar approach using the surgeon's incision of choice (i.e. patellar tendon split, tendon retraction medial, tendon retraction lateral)

Semi-extended suprapatellar approach using quadriceps split combined with purpose designed percutaneous instrumentation

Sponsors

Fraser Orthopaedic Research Society
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* all extra-articular tibial fractures * simple distal tibial intra-articular fractures amenable to IMN * open and closed fractures * bilateral tibiae * willing and able to consent, follow protocol and attend follow-up visits * able to read and understand English or have interpreter available

Exclusion criteria

* patients with contralateral femur and/or hip fracture requiring retrograde IMN * patients with contralateral knee injuries that would impair their ability to kneel during the follow-up period * associated knee injury * previous symptomatic knee pathology * ipsilateral injuries to the same limb that would interfere with rehab or outcome * neurovascular injuries at the level of the knee requiring surgery * open or closed fractures \> 14 days (times of injury to OR) * non unions * pathologic fractures * periprosthetic fractures * spinal injury * non-ambulatory patients * incarceration * limited life expectancy due to significant medical co-morbidities or medical contra-indication to surgery (pregnancy) * likely problems, in the judgment of the investigators, with maintaining follow-up

Design outcomes

Primary

MeasureTime frameDescription
VAS (visual analog scale) for pain on kneeling/ability to knee12 months post treatmentParticipants assessment of their degree/level of pain on kneeling after performing the AKT (Aberdeen Kneeling Weight-Distribution Test) on a 10 cm visual analog scale

Secondary

MeasureTime frameDescription
AST (Aberdeen Standing Weight-Distribution Test)4, 6, 12 and 24 months post treatmentThe AST involves the patient standing on two separate calibrated scales (one foot on each scale) and the weight in kg recorded with the patient blinded to the readings.
VAS (Visual Analog Scale) at rest, with walking and descending stairs4, 6, 12 and 24 months post treatmentParticipants overall assessment of their pain at rest, with walking and descending stairs over the past week on a 10 cm visual analog scale
Lysholm Knee Scoring Scale4, 6, 12 and 24 months post treatmentUsed to evaluate outcomes of knee ligament surgery using 8-items commonly affecting patients with anterior knee pain: Limp, support, locking, instability, pain, swelling, stair climbing and squatting.
AKT (Aberdeen Kneeling Weight-Distribution Test)4, 6, 12 and 24 months post treatmentThe AKT involves kneeling on two separate calibrated scales for up to 60 seconds with the patient blinded to the readings. At 15-second intervals the weight distribution, measured in kg, between the two knees is documented.
EQ-5D Health Related Quality of Life Outcome Measure4, 6,12 and 24 months post treatment5 dimensions: Mobility: self-care, usual activities, pain/discomfort and anxiety/depression
WPAI:SHP (Work Productivity and Activity Impairment: Specific Health Problem4, 6, 12 and 24 months post treatmentA questionnaire pertaining to the effect of the participants tibial fracture on their ability to work and perform regular activities.
Radiographic outcomeIntra-operatively and 4, 6,12 and 24 months post treatmentBlinded independent reviewer will adjudicate alignment, nail position and determination of union at one year, as well as change of position of the nail.
PKPM (Photographic knee pain map)4, 6,12 and 24 months post treatmentUsed to determine the precise location of the knee pain, as indicated and localized by the participant.

Countries

Canada, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026